DK1594500T3 - Behandling af bakterielle sygdomme i respirations-organerne ved lokal applikation af fluorkinoloner - Google Patents

Behandling af bakterielle sygdomme i respirations-organerne ved lokal applikation af fluorkinoloner

Info

Publication number: DK1594500T3
Authority: DK; Denmark
Prior art keywords: fluoroquinolones; treatment; local application; bacterial diseases; respiratory organs
Prior art date: 2003-02-10

Application number

DK04705765.8T

Other languages

English (en)

Inventor

Rainer Endermann

Uwe Petersen

Ben Newton

Christoph Ladel

Harald Labischinski

Original Assignee

Bayer Schering Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-10

Filing date

2004-01-28

Publication date

2011-01-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32851853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1594500(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-02-10 Priority claimed from DE10305318A external-priority patent/DE10305318A1/de

2003-02-10 Priority claimed from DE10305319A external-priority patent/DE10305319A1/de

2004-01-28 Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag

2011-01-24 Application granted granted Critical

2011-01-24 Publication of DK1594500T3 publication Critical patent/DK1594500T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Quinoline Compounds (AREA)

DK04705765.8T 2003-02-10 2004-01-28 Behandling af bakterielle sygdomme i respirations-organerne ved lokal applikation af fluorkinoloner DK1594500T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10305318A DE10305318A1 (de)	2003-02-10	2003-02-10	Behandlung bakteriell verursachter Lungenkrankheiten
DE10305319A DE10305319A1 (de)	2003-02-10	2003-02-10	Behandlung bakteriell verursachter Lungenkrankheiten
PCT/EP2004/000710 WO2004069253A1 (de)	2003-02-10	2004-01-28	Behandlung bakterieller erkrankungen der atmungsorgane durch lokale applikation von fluorchinolonen

Publications (1)

Publication Number	Publication Date
DK1594500T3 true DK1594500T3 (da)	2011-01-24

Family

ID=32851853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04705765.8T DK1594500T3 (da)	2003-02-10	2004-01-28	Behandling af bakterielle sygdomme i respirations-organerne ved lokal applikation af fluorkinoloner

Country Status (27)

Country	Link
US (2)	US8034817B2 (da)
EP (1)	EP1594500B1 (da)
JP (2)	JP4828405B2 (da)
KR (1)	KR101173696B1 (da)
AR (1)	AR043117A1 (da)
AT (1)	ATE482706T1 (da)
AU (1)	AU2004210399B2 (da)
BR (1)	BRPI0407368A (da)
CA (1)	CA2515262C (da)
CY (1)	CY1110998T1 (da)
DE (1)	DE502004011696D1 (da)
DK (1)	DK1594500T3 (da)
EC (1)	ECSP055959A (da)
HR (1)	HRP20050786B1 (da)
IL (1)	IL170027A (da)
MA (1)	MA27632A1 (da)
MX (1)	MXPA05008407A (da)
MY (1)	MY144714A (da)
NO (1)	NO331524B1 (da)
NZ (1)	NZ541681A (da)
PE (1)	PE20050189A1 (da)
PT (1)	PT1594500E (da)
RU (1)	RU2373937C9 (da)
SI (1)	SI1594500T1 (da)
TW (1)	TWI347843B (da)
UY (1)	UY28179A1 (da)
WO (1)	WO2004069253A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2004210399B2 (en) *	2003-02-10	2010-02-18	Bayer Intellectual Property Gmbh	Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones
US7157455B2 (en) *	2003-02-10	2007-01-02	Hoffmann-La Roche Inc.	4-Aminopyrimidine-5-one derivatives
WO2006033713A2 (en) *	2004-08-09	2006-03-30	Chiron Corporation	Methods for ciprofloxacin inhalation
BRPI0517374A (pt)	2004-10-29	2008-10-07	Harvard College	formulação para tratamento ou prevenção de infecção respiratória, método para tratamento
US8524735B2 (en)	2005-05-18	2013-09-03	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
RS55114B1 (sr) *	2005-05-18	2016-12-30	Raptor Pharmaceuticals Inc	Aerosolizovani fluorohinoloni i njihove upotrebe
RU2497524C2 (ru) *	2008-05-15	2013-11-10	Новартис Аг	Внутрилегочное введение флуорохинолона
PT2346509T (pt)	2008-10-07	2020-08-05	Horizon Orphan Llc	Inalação de levofloxacina para redução da inflamação pulmonar
NO2344129T3 (da)	2008-10-07	2018-07-21
WO2010048341A1 (en)	2008-10-22	2010-04-29	Inspire Pharmaceuticals, Inc.	Method for treating cystic fibrosis
BR112012004692B8 (pt)	2009-09-04	2021-05-25	Mpex Pharmaceuticals Inc	solução que compreende levofloxacina para uso em um método para tratar a fibrose cística em um ser humano
US9393243B1 (en)	2015-07-14	2016-07-19	Nilesh Parikh	Topical Ciprofloxacin compositions
WO2018074880A2 (ko) *	2016-10-20	2018-04-26	한국화학연구원	퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4670444B1 (en) *	1980-09-03	1999-02-09	Bayer Ag	and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3033157A1 (de)	1980-09-03	1982-04-01	Bayer Ag, 5090 Leverkusen	7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3525335A1 (de) *	1985-07-16	1987-01-22	Bayer Ag	Embonate von chinoloncarbonsaeuren und ihren derivaten
DE3906365A1 (de)	1988-07-15	1990-01-18	Bayer Ag	7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
FR2655545B1 (fr) *	1989-12-11	1994-06-10	Rhone Poulenc Sante	Nouvelle application therapeutique des derives des fluoroquinolones.
EP0504112A3 (en) *	1991-03-14	1993-04-21	Ciba-Geigy Ag	Pharmaceutical aerosol formulations
DE4200821A1 (de) *	1992-01-15	1993-07-22	Bayer Ag	Geschmacksmaskierte pharmazeutische mittel
RU2063770C1 (ru) *	1992-05-22	1996-07-20	Николай Сергеевич Скрипников	Способ лечения гнойно-воспалительных заболеваний легких
RU2070045C1 (ru) *	1993-01-15	1996-12-10	Вячеслав Михайлович Провоторов	Способ лечения хронического гнойного эндобронхита
DE19633480A1 (de) *	1996-08-20	1998-02-26	Bayer Ag	Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE19812160C1 (de) *	1998-03-20	1999-07-08	Bayer Ag	Formkörper aus wirkstoffhaltigen thermoplastischen Polyurethanen
AU5528299A (en) *	1998-09-15	2000-04-03	Naeja Pharmaceutical Inc.	Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s)
IL149085A0 (en) *	1999-10-29	2002-11-10	Inhale Therapeutic Syst	A dry powder composition containing a di or tripeptide
DE19962470A1 (de)	1999-12-22	2001-07-12	Schulz Hans Herrmann	Verwendung von Chemotherapeutika
DE10031043A1 (de) *	2000-06-26	2002-02-14	Bayer Ag	Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
CA2477982A1 (en) *	2002-03-05	2003-09-18	Transave, Inc.	Methods for entrapment of bioactive agent in a liposome or lipid complex
EP1501483A2 (en) *	2002-04-25	2005-02-02	Nektar Therapeutics UK Ltd	Particulate materials
AU2004210399B2 (en) *	2003-02-10	2010-02-18	Bayer Intellectual Property Gmbh	Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones

2004
- 2004-01-28 AU AU2004210399A patent/AU2004210399B2/en not_active Ceased
- 2004-01-28 PT PT04705765T patent/PT1594500E/pt unknown
- 2004-01-28 BR BRPI0407368-1A patent/BRPI0407368A/pt not_active Application Discontinuation
- 2004-01-28 CA CA2515262A patent/CA2515262C/en not_active Expired - Fee Related
- 2004-01-28 SI SI200431572T patent/SI1594500T1/sl unknown
- 2004-01-28 KR KR1020057014646A patent/KR101173696B1/ko not_active Expired - Fee Related
- 2004-01-28 RU RU2005128132/14A patent/RU2373937C9/ru not_active IP Right Cessation
- 2004-01-28 HR HRP20050786AA patent/HRP20050786B1/hr not_active IP Right Cessation
- 2004-01-28 NZ NZ541681A patent/NZ541681A/en not_active IP Right Cessation
- 2004-01-28 WO PCT/EP2004/000710 patent/WO2004069253A1/de not_active Ceased
- 2004-01-28 DE DE502004011696T patent/DE502004011696D1/de not_active Expired - Lifetime
- 2004-01-28 DK DK04705765.8T patent/DK1594500T3/da active
- 2004-01-28 MX MXPA05008407A patent/MXPA05008407A/es active IP Right Grant
- 2004-01-28 EP EP04705765A patent/EP1594500B1/de not_active Expired - Lifetime
- 2004-01-28 JP JP2006501628A patent/JP4828405B2/ja not_active Expired - Fee Related
- 2004-01-28 AT AT04705765T patent/ATE482706T1/de active
- 2004-02-06 UY UY28179A patent/UY28179A1/es not_active Application Discontinuation
- 2004-02-06 AR ARP040100382A patent/AR043117A1/es unknown
- 2004-02-06 MY MYPI20040367A patent/MY144714A/en unknown
- 2004-02-09 TW TW093102878A patent/TWI347843B/zh not_active IP Right Cessation
- 2004-02-09 PE PE2004000145A patent/PE20050189A1/es not_active Application Discontinuation
- 2004-02-10 US US10/775,888 patent/US8034817B2/en not_active Expired - Fee Related
2005
- 2005-08-02 IL IL170027A patent/IL170027A/en active IP Right Grant
- 2005-08-10 EC EC2005005959A patent/ECSP055959A/es unknown
- 2005-09-08 NO NO20054180A patent/NO331524B1/no not_active IP Right Cessation
- 2005-09-09 MA MA28491A patent/MA27632A1/fr unknown
2010
- 2010-12-17 CY CY20101101161T patent/CY1110998T1/el unknown
2011
- 2011-06-08 JP JP2011128600A patent/JP2011173929A/ja active Pending
- 2011-07-28 US US13/192,893 patent/US20120010215A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1594500A1 (de)	2005-11-16
NZ541681A (en)	2009-02-28
EP1594500B1 (de)	2010-09-29
RU2373937C2 (ru)	2009-11-27
HRP20050786A2 (en)	2006-10-31
MXPA05008407A (es)	2005-10-05
ECSP055959A (es)	2006-01-16
MY144714A (en)	2011-10-31
WO2004069253A1 (de)	2004-08-19
ATE482706T1 (de)	2010-10-15
NO20054180D0 (no)	2005-09-08
TWI347843B (en)	2011-09-01
BRPI0407368A (pt)	2006-02-14
US20120010215A1 (en)	2012-01-12
RU2005128132A (ru)	2006-02-10
NO20054180L (no)	2005-09-08
CA2515262C (en)	2013-09-03
JP4828405B2 (ja)	2011-11-30
US8034817B2 (en)	2011-10-11
UY28179A1 (es)	2004-09-30
NO331524B1 (no)	2012-01-23
PT1594500E (pt)	2010-12-17
JP2011173929A (ja)	2011-09-08
IL170027A (en)	2012-02-29
HRP20050786B1 (hr)	2015-01-02
KR101173696B1 (ko)	2012-08-13
AR043117A1 (es)	2005-07-20
KR20050098309A (ko)	2005-10-11
PE20050189A1 (es)	2005-05-22
AU2004210399A1 (en)	2004-08-19
CA2515262A1 (en)	2004-08-19
SI1594500T1 (sl)	2011-02-28
HK1089380A1 (zh)	2006-12-01
MA27632A1 (fr)	2005-11-01
RU2373937C9 (ru)	2010-07-27
AU2004210399B2 (en)	2010-02-18
CY1110998T1 (el)	2015-06-11
DE502004011696D1 (de)	2010-11-11
US20040254194A1 (en)	2004-12-16
TW200503716A (en)	2005-02-01
JP2006517210A (ja)	2006-07-20

Publication	Publication Date	Title
EA200802213A1 (ru)	2009-10-30	Способы лечения заболеваний крови
DK1556342T3 (da)	2008-07-21	Phenethanolaminderivat til behandling af respiratoriske sygdomme
DK1944322T3 (da)	2015-06-22	Behandling af TNFalfa-relaterede sygdomme
DE602004020072D1 (de)	2009-04-30	1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
HUS1500058I1 (hu)	2016-01-28	Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
DE602005017636D1 (de)	2009-12-24	Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen
DE60303238D1 (de)	2006-04-06	Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
IL224393B (en)	2018-06-28	Compositions for treatment of huntington's disease
ATE369333T1 (de)	2007-08-15	Sulfonamidderivate zur behandlung von krankheiten
DE602005023172D1 (de)	2010-10-07	Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE375977T1 (de)	2007-11-15	Sulfonamidderivate zur behandlung von krankheiten
ATE447551T1 (de)	2009-11-15	Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE476414T1 (de)	2010-08-15	Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ATE443704T1 (de)	2009-10-15	Pyridopyrimidinone zur behandlung von krebserkrankungen
DK1594500T3 (da)	2011-01-24	Behandling af bakterielle sygdomme i respirations-organerne ved lokal applikation af fluorkinoloner
ATE510536T1 (de)	2011-06-15	Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
FI20095600L (fi)	2009-06-09	Koostumus ihosairauksien hoitoa varten
EP1965827A4 (en)	2009-12-23	TREATMENT OF CONDITIONS RELATED TO DEMYELINATION
DK1670482T4 (da)	2022-08-22	Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
DK1962869T3 (da)	2013-06-24	Behandling af luftvejssygdomme
DE502006007982D1 (de)	2010-11-11	Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
EP1494696A4 (en)	2006-01-25	TREATMENT OF PULMONARY DISORDERS
DK1687297T3 (da)	2014-09-22	Triazindimerer til behandling af autoimmunsygdomme
DK1744781T3 (da)	2012-10-15	Behandling af infektionssygdomme
DE502006008804D1 (de)	2011-03-10	Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen